Overall rank by patents
#3,324
Across all tracked assignees
USPTO PatentsView assignee record — 112 granted patents across 26 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Fred holds 112 US patents across 26 technology areas — rank #3,324 of 50,000 tracked assignees.
Fred Hutchinson Cancer Research Center has been granted 112 US utility patents between 2015 and 2025, placing Fred Hutchinson Cancer Research Center at rank #3,324 across all assignees tracked by PlainPatent. This portfolio spans 26 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.9 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Fred Hutchinson Cancer Research Center is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 46.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 57 grants, compared with 55 in the 2015–2019 window — a +4% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Fred Hutchinson Cancer Research Center's 18.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 26 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fred Hutchinson Cancer Research Center against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
International Business Machines Corporation
72,926 patents
Canon Kabushiki Kaisha
34,378 patents
LG ELECTRONICS INC.
32,607 patents
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
Apple Inc.
30,560 patents
QUALCOMM Incorporated
30,354 patents
Intel Corporation
27,498 patents
Fred Hutchinson Cancer Research Center
112 patents
What this shows Fred holds 112 patents — placing it at rank #3,324 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Fred's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
47 Top 20% higher than 80% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 9 | 8.0% |
| 2016 | 5 | 4.5% |
| 2017 | 11 | 9.8% |
| 2018 | 11 | 9.8% |
| 2019 | 19 | 17.0% |
| 2020 | 27 | 24.1% |
| 2021 | 19 | 17.0% |
| 2022 | 4 | 3.6% |
| 2023 | 1 | 0.9% |
| 2024 | 4 | 3.6% |
| 2025 | 2 | 1.8% |
Top 15 of 26 technology areas
Overall rank by patents
#3,324
Across all tracked assignees
46.6 out of 100
Fred Hutchinson Cancer Research Center's primary CPC class — all holders and yearly trends
See where Fred Hutchinson Cancer Research Center ranks among the largest US patent assignees
Browse every CPC technology area by patent activity
The four dimensions behind the Innovation Score
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.